1-16 of 16
Keywords: Prostate cancer
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2013) 36 (10): 592–596.
Published Online: 16 September 2013
...Fang-Zhi Chen; Xiao-Kun Zhao Prostate cancer is one of the most common cancers in men. Various signaling pathways and proteins are involved in prostate carcinogenesis. Ubiquitination and deubiquitination of the related proteins contribute to the development of prostate cancer in various ways...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2010) 33 (4): 169–173.
Published Online: 19 March 2010
.... The mean follow-up period was 56 months. Results: Of the 14 patients managed with radiotherapy, 1 patient developed bone metastases and died of prostate cancer, and 1 patient had a biochemical relapse 8 years after definitive radiotherapy. Of the 16 patients who underwent radical prostatectomy, 2 patients...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2009) 32 (10): 586–588.
Published Online: 11 September 2009
... prostatitis by its pattern of infiltration and by immunohistochemistry. As the incidence of both SLL/CLL and prostatic carcinoma increases with age, composite tumours might occur more often in the future. CLL Prostate infiltration Urinary obstruction Prostate cancer © 2009 S. Karger AG, Basel 2009...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2009) 32 (6): 359–363.
Published Online: 14 May 2009
...Barbara Alicja Jereczek-Fossa; Giuseppe Curigliano; Roberto Orecchia The standard treatment options based on the risk category for non-metastatic prostate cancer include surgery, radiotherapy, and watchful waiting (and more recently, active surveillance). The treatment outcome is satisfactory...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1996) 19 (4): 302–307.
Published Online: 12 May 2009
...J.E. Altwein; J. Silchinger Maximal androgen blockade (MAB) using leuprorelin or goserelin plus flutamide provides a significant survival advantage in patients with D 2 prostate cancer. It is noteworthy that in a nonconcurrent comparison leuprorelin plus flutamide was more effective than...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1993) 16 (3): 150–157.
Published Online: 08 May 2009
... of elevated prostate-specific antigen (PSA). The technique is advantageous in monitoring therapy (medical treatment for benign prostatic hyperplasia (BPH) or follow-up of prostate cancer). It is the best available imaging modality in the follow-up of patients after external or interstitial irradiation...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2009) 32 (5): 260–262.
Published Online: 20 April 2009
...Mashal Abdallah; Irina Lazarev; Samuel Ariad; Wilmosh Mermershtain Background: The aim of the study was to investigate whether the awareness of prostate cancer among Bedouin men is low or whether the incidence of prostate cancer is truly low among the Bedouin population. Patients and Methods: Total...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2009) 32 (3): 122–124.
Published Online: 18 February 2009
... occurring in the prostate, kidney and urinary bladder. Case Report: A 70-year-old man with prostate cancer presented with the complaint of hematuria. Computed tomography (CT) showed increased wall thickness of the urinary bladder with an enlarged prostate. After the trans-urothelial resection operation...
Journal Articles